Cargando…

Efficacy, retention, and safety of tofacitinib in real-life: Hur-bio monocentric experience

BACKGROUND/AIM: To assess the real-life efficacy, retention rate, and safety data of tofacitinib in rheumatoid arthritis (RA) patients. MATERIALS AND METHODS: We analyzed all patients registered in the HURBİO database who received at least 1 dose of tofacitinib. Patients who received at least one do...

Descripción completa

Detalles Bibliográficos
Autores principales:	BİLGİN, Emre, CEYLAN, Furkan, DURAN, Emine, FARİSOĞULLARI, Bayram, BÖLEK, Ertuğrul Çağrı, YARDIMCI, Gözde Kübra, KILIÇ, Levent, AKDOĞAN, Ali, KARADAĞ, Ömer, BİLGEN, Şule Apraş, KİRAZ, Sedat, ERTENLİ, Ali İhsan, KALYONCU, Umut
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Scientific and Technological Research Council of Turkey 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991862/ https://www.ncbi.nlm.nih.gov/pubmed/32979899 http://dx.doi.org/10.3906/sag-2007-123

Ejemplares similares

Hematologic Malignancy Risk in Inflammatory Arthritis Patients Treated with TNF Inhibitors: The Real-Life Data from the HUR-BIO Registry
por: Duran, Emine, et al.
Publicado: (2023)

Anti-interleukin-6 (tocilizumab) therapy in Takayasu’s arteritis: a real life experience
por: KILIÇ, Levent, et al.
Publicado: (2020)

The impact of antiphospholipid antibodies in Takayasu arteritis
por: FIRAT ŞENTÜRK, Esra, et al.
Publicado: (2022)

Avascular necrosis less frequently found in systemic lupus erythematosus patients with the use of alternate day corticosteroid
por: DOGAN, İsmail, et al.
Publicado: (2020)

Starting of biological disease modifying antirheumatic drugs may be postponed in rheumatoid arthritis patients with multimorbidity: Single center real life results
por: Armagan, Berkan, et al.
Publicado: (2018)

Rituximab Therapy in Renal Amyloidosis Secondary to Rheumatoid Arthritis
por: Kilic, Levent, et al.
Publicado: (2018)

Increased psoriasis frequency in patients with familial Mediterranean fever
por: Erden, Abdulsamet, et al.
Publicado: (2018)

The DETAIL questionnaire is a useful and effective tool to assess spondyloarthritis in patients with inflammatory bowel disease
por: Keskin, Onur, et al.
Publicado: (2023)

How did the updated hemodynamic definitions affect the frequency of pulmonary hypertension in patients with systemic sclerosis?
por: Sarı, Alper, et al.
Publicado: (2020)

The frequency of Achilles and plantar calcaneal spurs in gout patients
por: DURAN, Emine, et al.
Publicado: (2021)

Pulmonary hypertension in Behçet’s disease: echocardiographic screening and multidisciplinary approach
por: ARMAĞAN, Berkan, et al.
Publicado: (2023)

Imaging modalities used in diagnosis and follow-up of patients with Takayasu’s arteritis
por: KELEŞOĞLU DİNÇER, Ayşe Bahar, et al.
Publicado: (2021)

Effectiveness of a supervised group exercise therapy based on the biopsychosocial model introduced simultaneously with anti-TNF therapy in anti-TNF-naive patients with active ankylosing spondylitis
por: KARACA, Nur Banu, et al.
Publicado: (2022)

Preferences of inflammatory arthritis patients for biological disease-modifying antirheumatic drugs in the first 100 days of the COVID-19 pandemic
por: KALYONCU, Umut, et al.
Publicado: (2021)

Capillaroscopic findings in Turkish Takayasu arteritis patients
por: AKDOĞAN, Ali, et al.
Publicado: (2019)

Differences and similarities of proliferative and non-proliferative forms of biopsy-proven lupus nephritis: Single centre, cross-disciplinary experience
por: Duran, Emine, et al.
Publicado: (2022)

Proposal of a new nomenclature for the underlying pathogenetic mechanism of severe Coronavirus Disease-19: “Inflammatory Thrombosis with Immune Endotheliitis—ITIE”
por: Bilgin, Emre, et al.
Publicado: (2021)

Geoepidemiology and clinical characteristics of neonatal lupus erythematosus: a systematic literature review of individual patients’ data
por: ERDEN, Abdulsamet, et al.
Publicado: (2020)

The First Effect of COVID-19 Pandemic on Starting Biological Disease Modifying Anti-Rheumatic Drugs: Outcomes from the TReasure Real-Life Database
por: Alpay Kanıtez, Nilüfer, et al.
Publicado: (2022)

AI am a rheumatologist: a practical primer to large language models for rheumatologists
por: Venerito, Vincenzo, et al.
Publicado: (2023)

Temperature change in pulp chamber of primary teeth during curing of coloured compomers: an in vitro study using pulpal blood microcirculation model
por: Ertuğrul, Ceylan Çağıl, et al.
Publicado: (2019)

Epidemiological characteristics of hepatitis B and C in patients with inflammatory arthritis: Implications from treasure database
por: Ersözlü, Emine Duygu, et al.
Publicado: (2022)

MEFV gene methylation pattern analysis in familial Mediterranean fever patients with altered expression levels
por: Ulum, YZ Akkaya, et al.
Publicado: (2015)

Should our approach to diuretic using in patients with gout change?
por: Tecer, Duygu, et al.
Publicado: (2018)

Real-life experience of tofacitinib in patients with treatment-resistant rheumatoid arthritis: A 5-year follow-up: Monocentric experience
por: Pehlivan, Ozlem
Publicado: (2022)

Colchicine intolerance in FMF patients and primary obstacles for optimal dosing
por: SATIŞ, Hasan, et al.
Publicado: (2020)

Effect of non-repetitive linker on in vitro and in vivo properties of an anti-VEGF scFv
por: Arslan, Merve, et al.
Publicado: (2022)

Extremely high erythrocyte sedimentation rate revisited in rheumatic diseases: a single-center experience
por: ÖZSOY, Zehra, et al.
Publicado: (2022)

Phenotypic characterization of Familial Mediterranean Fever patients harboring variants of uncertain significance
por: SARI, Alper, et al.
Publicado: (2021)

Appendectomy history is associated with severe disease and colchicine resistance in adult familial Mediterranean fever patients
por: BODAKÇİ, Erdal, et al.
Publicado: (2021)

Reduced nuclear export of HuR mRNA by HuR is linked to the loss of HuR in replicative senescence
por: Yi, Jie, et al.
Publicado: (2010)

Tofacitinib
Publicado: (2012)

P01-003 – Bleeding disorder in FMF
por: Karadag, O, et al.
Publicado: (2013)

MCD Diet Modulates HuR and Oxidative Stress-Related HuR Targets in Rats
por: Ferrigno, Andrea, et al.
Publicado: (2023)

Erratum to Tofacitinib
Publicado: (2012)

Ben-Hur : una historia de los tiempos de Cristo
por: Wallace, Lew, 1827-1905
Publicado: (1972)

Circ-HuR suppresses HuR expression and gastric cancer progression by inhibiting CNBP transactivation
por: Yang, Feng, et al.
Publicado: (2019)

The Potential Prognostic Marker TyG Index Predicts Time to Brain Metastasis at HER2 Positive Breast Cancer
por: Karadag, Ibrahim, et al.
Publicado: (2023)

Bioequivalence of the pharmacokinetics between tofacitinib aspartate and tofacitinib citrate in healthy subjects
por: Shin, Wonsuk, et al.
Publicado: (2020)

Tofacitinib reduces mortality in coronavirus disease 2019 Tofacitinib in COVID-19
por: Maslennikov, Roman, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9l634o9ktrosc43q4gsv1nfque